Oral Antiviral Drug, Molnupiravir, Phase 1 Clinical Trial
Автор: Investigate Explore Discover
Загружено: 2021-12-06
Просмотров: 437
Описание:
In this video, I outline the phase 1 clinical trial of molnupiravir, a broad-spectrum antiviral oral medication developed by Ridgeline Therapeutics, now in collaboration with Merck. These data show the safety profile and pharmacokinetics of molnupiravir for the first time in humans.
This video summarises the paper: Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2.
by: Wendy P Painter, Wayne Holman, Jim A Bush, Firas Almazedi, Hamzah Malik, Nicola C J E Eraut, Merribeth J Morin, Laura J Szewczyk, George R Painter
This is a link to where you can find a copy of the article for yourself to read:
https://journals.asm.org/doi/10.1128/...
Sections:
0:00 Introduction
6:10 Importance
6:44 Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2.
7:16 Results
12:08 Summary
12:31 Significance
12:56 Future Directions
To get a free NFT, go to my Twitter and follow the instructions on the tweet about this video.
Twitter: / invexdis
Show your support with a coffee :)
https://www.buymeacoffee.com/InvExDis
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Эффект Джанибекова [Veritasium]](https://imager.clipsaver.ru/N9HlQ-XVnFk/max.jpg)
![Пожалуй, главное заблуждение об электричестве [Veritasium]](https://imager.clipsaver.ru/6Hv2GLtnf2c/max.jpg)
